SCYX

Conviction 80HealthcareScan · Mon, Aug 10, 2026

SCYX$5.16-1.62%

ResistanceSupportVol 14

Vol MA14 328.52K

May 11May 28Jun 16Jul 6Jul 23Aug 10

SCYNEXIS INCPHARMACEUTICAL PREPARATIONSwww.scynexis.com ↗

Price5.16

Change-1.62%

Gap+1.91%

Rel volume0.08×

Avg volume243.63K

Avg $ vol1.16M

SMA 204.44

SMA 504.30

SMA 2001.65

Price vs 50+19.93%

Price vs 200+212.44%

MA stackbullish

50/200 cross—

Supertrendup · 4.03

RSI (14)64

MACD hist0.10

MACD crossbull · 5d

Stoch %K / %D81 / 83

ADX (14)32

+DI / −DI30 / 12

RSI divergence—

MACD divergence—

ATR %+8.05%

ADR %9.74%

52w high5.40

52w low0.5773

From 52w high-4.54%

Above 52w low+792.95%

New 52w highNo

SqueezeOff

Bollinger width56.70%

%B0.78

Donchian pos80.85%

Donchian high5.54

Donchian low3.53

AVWAP (52w high)4.46

vs AVWAP high+15.46%

AVWAP (52w low)1.14

vs AVWAP low+351.77%

OBV trendUp

Chaikin MF (20)0.55

Today vs 20d0.08×

Avg vol (14d)328.52K

Avg vol (20d)243.63K

Avg $ vol (20d)1.16M

Market cap51.29M

RS 3m (vs SPY)+441.68%

RS 6m (vs SPY)+644.87%

RS line new highNo

Trend template8/8

Technical rank92.7

1 week+1.68%

1 month+17.69%

3 months+462.96%

6 months+579.18%

1 year+489.14%

YTD+707.36%

P/E-5.96

P/B0.77

P/S2.49

P/FCF-9.71

EPS-0.1700

Div yield—

ROE-12.86%

ROA-11.48%

Debt/Eq0.00

Current9.65

EV/EBITDA-2.54

Gross margin17.37%

Net margin-41.79%

Rev growth449.95%

EPS growth59.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value40.8M

Revenue235K

Net income7.4M

Gross profit66K

Free cash flow-5.28M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees29

ListedFri, May 2, 2014

Free float42.44M

Float %95.0%

Short interest347.56K

Days to cover3.5d

Short volume55.5%

Squeeze score29 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank92.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.32

Support3.53

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCYX

All disclosures →

No recent disclosed trades by Congress in SCYX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCYX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
HANHAM ANN Director · Common Stock · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
ANIDO ARMANDO Director · Common Stock · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
ANIDO ARMANDO Director · Stock Option (Right to Buy) · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
HANHAM ANN Director · Stock Option (Right to Buy) · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
HASTINGS DAVID C Director · Common Stock · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
HASTINGS DAVID C Director · Stock Option (Right to Buy) · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
Macdonald Guy Director · Common Stock · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
Macdonald Guy Director · Stock Option (Right to Buy) · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
Tinmouth Brian Philippe Director · Common Stock · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30
Tinmouth Brian Philippe Director · Stock Option (Right to Buy) · 2026-06-26	Grant	2.88K	—	2026-06-26	2026-06-30

SEC filings

EDGAR filings in SCYX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.